FDA Approved: FULVESTRANT — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for fulvestrant by Sandoz Inc. under ANDA 205935, representing a supplemental approval for a generic fulvestrant pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fulvestrant (fulvestrant)

Snippet

SUPPL AP for FULVESTRANT (FULVESTRANT)